resources

Alembic Pharmaceuticals Ltd.

NSE: APLLTD

BSE: 533573

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

764.90-15.8 (-2.02%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Alembic Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	13May 2Aug 19Nov	16Feb 9May 10Aug 17Nov	7Feb 12May 9Aug 10Nov	18Jan 9Feb 15May 14Aug 12Nov	12May 11Aug 11Nov	21May 10Aug
Presentations	—	—	—	—	—	—	—	—	—	—	5May 4Aug 7Nov	5Feb 9May 8Aug 7Nov	3Feb 6May 5Aug 4Nov	5Feb 15May 4Aug

Corporate Announcements and Regulatory Filings

Alembic Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General19 Oct 2026
Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015
Please find attached herewith the Intimation under Regulation 30 of SEBI LODR Regulations, 2015
Press Release / Media Release17 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension USP 0.3% / 0.1%
Newspaper Publication8 Oct 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the copy of Newspaper Publication.
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201129 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others
Closure of Trading Window28 Sept 2026
Closure of Trading Window
Please find enclosed Intimation of Trading Window Closure.
Analyst / Investor Meet18 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed Intimation of One to One Investor Meet.
General16 Sept 2026
Update On USFDA Inspection Conducted During 3Rd March, 2025 To 7Th March, 2025 At Bioequivalence Facility Located At Vadodara, Gujarat.
Update on USFDA inspection conducted during 3rd March, 2025 to 7th March, 2025 at Bioequivalence Facility located at Vadodara, Gujarat.
General11 Sept 2026
Intimation Regarding Successful Completion Of Unannounced USFDA Onsite Bioequivalence Inspection.
Successful completion of unannounced USFDA onsite inspection at Alembic Pharmaceuticals Limited''s Bioequivalence Facility in Vadodara, Gujarat.
General7 Sept 2026
Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of A Wholly Owned Subsidiary Company
Please find enclosed herewith the Intimation regarding Incorporation of a wholly owned subsidiary company of the Company.
Analyst / Investor Meet27 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached.
Analyst / Investor Meet27 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached.
Newspaper Publication25 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached.
Appointment of Company Secretary / Compliance Officer20 Aug 2026
Appointment of Company Secretary and Compliance Officer
Intimation regarding Appointment of Company Secretary of the Company.
Newspaper Publication11 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached.
Resignation of Company Secretary / Compliance Officer10 Aug 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Please find attached.
AGM6 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August, 2026.
AGM5 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached Proceedings of AGM held on 5th August, 2026.
Newspaper Publication5 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the Newspaper Advertisement.
Analyst / Investor Meet4 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find attached audio recording of investor call.

Frequently Asked Questions

Where can I download the annual report of Alembic Pharmaceuticals Ltd.?

Annual reports of Alembic Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Alembic Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Alembic Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Alembic Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Alembic Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Alembic Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Alembic Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Alembic Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Alembic Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Alembic Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alembic Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Alembic Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Alembic Pharmaceuticals Ltd. is INE901L01018. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Alembic Pharmaceuticals Ltd. listed?

Alembic Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is APLLTD and the BSE code is -.

Where can I find the shareholding pattern of Alembic Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Alembic Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Alembic Pharmaceuticals Ltd. on Sharpely?

Share price data for Alembic Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.